These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 19039027

  • 1. Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair.
    Elshal M, Abdelaziz A, Abbas A, Mahmoud K, Fathy H, El Mongy S, El-Basyuoni S, Ahmed H, McCoy P.
    Nephrol Dial Transplant; 2009 May; 24(5):1495-9. PubMed ID: 19039027
    [Abstract] [Full Text] [Related]

  • 2. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J, Kopeć W, Jakobsche-Policht U, Adamiec R.
    Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
    [Abstract] [Full Text] [Related]

  • 3. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis.
    Del Papa N, Colombo G, Fracchiolla N, Moronetti LM, Ingegnoli F, Maglione W, Comina DP, Vitali C, Fantini F, Cortelezzi A.
    Arthritis Rheum; 2004 Apr; 50(4):1296-304. PubMed ID: 15077314
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
    Heshmat NM, El-Kerdany TH.
    Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
    [Abstract] [Full Text] [Related]

  • 5. Circulating endothelial cells as a marker of vascular dysfunction in patients with systemic lupus erythematosus by real-time polymerase chain reaction.
    Attia FM, Maaty A, Kalil FA.
    Arch Pathol Lab Med; 2011 Nov; 135(11):1482-5. PubMed ID: 22032577
    [Abstract] [Full Text] [Related]

  • 6. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
    Kluz J, Kopeć W, Jakobsche U, Prajs I, Adamiec R.
    Postepy Hig Med Dosw (Online); 2007 Dec 03; 61():725-35. PubMed ID: 18063917
    [Abstract] [Full Text] [Related]

  • 7. Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis.
    el-Gamal YM, Heshmat NM, el-Kerdany TH, Fawzy AF.
    Pediatr Allergy Immunol; 2004 Jun 03; 15(3):270-7. PubMed ID: 15209962
    [Abstract] [Full Text] [Related]

  • 8. Circulating endothelial cells in preeclampsia.
    Canbakan B, Keven K, Tutkak H, Danisman N, Ergun I, Nergizoglu G.
    J Hum Hypertens; 2007 Jul 03; 21(7):558-63. PubMed ID: 17429447
    [Abstract] [Full Text] [Related]

  • 9. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E.
    Arthritis Rheum; 2004 Nov 03; 50(11):3610-5. PubMed ID: 15529371
    [Abstract] [Full Text] [Related]

  • 10. Circulating activated endothelial cells in systemic lupus erythematosus: further evidence for diffuse vasculopathy.
    Clancy R, Marder G, Martin V, Belmont HM, Abramson SB, Buyon J.
    Arthritis Rheum; 2001 May 03; 44(5):1203-8. PubMed ID: 11352255
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A, Ciolkiewicz M, Klimiuk PA, Sierakowski S.
    Scand J Rheumatol; 2009 May 03; 38(1):38-45. PubMed ID: 18991188
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
    Kuryliszyn-Moskal A, Klimiuk PA, Ciolkiewicz M, Sierakowski S.
    J Rheumatol; 2008 Jul 03; 35(7):1307-13. PubMed ID: 18484695
    [Abstract] [Full Text] [Related]

  • 13. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
    Makin AJ, Blann AD, Chung NA, Silverman SH, Lip GY.
    Eur Heart J; 2004 Mar 03; 25(5):371-6. PubMed ID: 15033248
    [Abstract] [Full Text] [Related]

  • 14. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
    Kümpers P, David S, Haubitz M, Hellpap J, Horn R, Bröcker V, Schiffer M, Haller H, Witte T.
    Ann Rheum Dis; 2009 Oct 03; 68(10):1638-43. PubMed ID: 18930996
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of renal vascular lesions using circulating endothelial cells in patients with lupus nephritis.
    Yao G, Liu ZH, Zheng C, Zhang X, Chen H, Zeng C, Li LS.
    Rheumatology (Oxford); 2008 Apr 03; 47(4):432-6. PubMed ID: 18292121
    [Abstract] [Full Text] [Related]

  • 16. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J, Dong J, Li Y, Liu YQ, Yang J, Wu Y, Li L, Shen GX, Tan ZJ, Tu YT.
    J Eur Acad Dermatol Venereol; 2009 Apr 03; 23(4):433-7. PubMed ID: 19335730
    [Abstract] [Full Text] [Related]

  • 17. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
    Lee KW, Blann AD, Lip GY.
    Int J Cardiol; 2006 Aug 10; 111(2):302-8. PubMed ID: 16324758
    [Abstract] [Full Text] [Related]

  • 18. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
    El-Banawy HS, Gaber EW, Maharem DA, Matrawy KA.
    J Nephrol; 2012 Aug 10; 25(4):541-50. PubMed ID: 21956768
    [Abstract] [Full Text] [Related]

  • 19. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.
    Goodale D, Phay C, Brown W, Gray-Statchuk L, Furlong P, Lock M, Chin-Yee I, Keeney M, Allan AL.
    Cytometry B Clin Cytom; 2009 Mar 10; 76(2):107-17. PubMed ID: 18727054
    [Abstract] [Full Text] [Related]

  • 20. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE).
    Schiffer L, Kümpers P, Davalos-Misslitz AM, Haubitz M, Haller H, Anders HJ, Witte T, Schiffer M.
    Nephrol Dial Transplant; 2009 Dec 10; 24(12):3708-12. PubMed ID: 19602475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.